C
China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
HKEX:1763
Price:
18.6
HKD
-2.11%
Market Closed
Market Cap:
HK$5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
CN |
|
Profit Cultural and Creative Group Co Ltd
SZSE:300640
|
CN |
|
W
|
WeP Solutions Ltd
BSE:532373
|
IN |
|
P
|
Pioneer Global Group Ltd
HKEX:224
|
HK |
|
Trent Ltd
NSE:TRENT
|
IN |
|
Kweichow Moutai Co Ltd
SSE:600519
|
CN |
|
A
|
Alfi Inc
OTC:ALFIQ
|
US |
Income Statement
Earnings Waterfall
China Isotope & Radiation Corp
China Isotope & Radiation Corp
Income Statement
China Isotope & Radiation Corp
China Isotope & Radiation Corp
Currency: CNY
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
12
|
25
|
27
|
26
|
28
|
29
|
28
|
27
|
26
|
35
|
41
|
0
|
|
| Revenue |
3 989
N/A
|
3 851
-3%
|
4 274
+11%
|
4 815
+13%
|
5 144
+7%
|
5 705
+11%
|
6 154
+8%
|
6 273
+2%
|
6 635
+6%
|
6 705
+1%
|
7 575
+13%
|
7 622
+1%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(1 160)
|
(1 365)
|
(1 658)
|
(1 719)
|
(1 902)
|
(2 258)
|
(2 636)
|
(2 803)
|
(3 153)
|
(3 243)
|
(3 892)
|
(3 944)
|
|
| Gross Profit |
2 829
N/A
|
2 486
-12%
|
2 616
+5%
|
3 096
+18%
|
3 242
+5%
|
3 447
+6%
|
3 518
+2%
|
3 470
-1%
|
3 482
+0%
|
3 462
-1%
|
3 683
+6%
|
3 678
0%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(2 158)
|
(1 977)
|
(2 034)
|
(2 408)
|
(2 497)
|
(2 654)
|
(2 681)
|
(2 566)
|
(2 757)
|
(2 632)
|
(2 602)
|
(2 554)
|
|
| Selling, General & Administrative |
(2 177)
|
(2 011)
|
(1 916)
|
(2 200)
|
(2 329)
|
(2 461)
|
(2 394)
|
(2 307)
|
(2 476)
|
(2 405)
|
(2 374)
|
(2 328)
|
|
| Research & Development |
0
|
0
|
(153)
|
(233)
|
(196)
|
(233)
|
(301)
|
(319)
|
(306)
|
(282)
|
(300)
|
(314)
|
|
| Other Operating Expenses |
20
|
34
|
35
|
26
|
28
|
40
|
14
|
61
|
24
|
56
|
72
|
88
|
|
| Operating Income |
672
N/A
|
509
-24%
|
582
+14%
|
688
+18%
|
745
+8%
|
794
+7%
|
837
+5%
|
904
+8%
|
725
-20%
|
830
+15%
|
1 081
+30%
|
1 125
+4%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
63
|
52
|
22
|
22
|
62
|
50
|
53
|
61
|
23
|
(15)
|
(9)
|
(16)
|
|
| Non-Reccuring Items |
(1)
|
0
|
(1)
|
0
|
4
|
0
|
39
|
0
|
185
|
159
|
(19)
|
(16)
|
|
| Total Other Income |
0
|
0
|
(8)
|
0
|
(7)
|
(7)
|
(8)
|
(7)
|
(10)
|
(10)
|
(7)
|
(8)
|
|
| Pre-Tax Income |
734
N/A
|
561
-24%
|
596
+6%
|
710
+19%
|
803
+13%
|
836
+4%
|
921
+10%
|
958
+4%
|
922
-4%
|
964
+5%
|
1 045
+8%
|
1 084
+4%
|
|
| Net Income | |||||||||||||
| Tax Provision |
(109)
|
(83)
|
(121)
|
(139)
|
(130)
|
(152)
|
(166)
|
(161)
|
(146)
|
(165)
|
(166)
|
(170)
|
|
| Income from Continuing Operations |
625
|
477
|
476
|
571
|
673
|
685
|
755
|
797
|
776
|
799
|
880
|
914
|
|
| Income to Minority Interest |
(296)
|
(224)
|
(262)
|
(322)
|
(337)
|
(344)
|
(363)
|
(391)
|
(405)
|
(401)
|
(473)
|
(490)
|
|
| Net Income (Common) |
329
N/A
|
253
-23%
|
214
-16%
|
248
+16%
|
336
+35%
|
341
+2%
|
392
+15%
|
406
+3%
|
371
-9%
|
399
+7%
|
407
+2%
|
424
+4%
|
|
| EPS (Diluted) |
1.03
N/A
|
0.79
-23%
|
0.67
-15%
|
0.78
+16%
|
1.05
+35%
|
1.07
+2%
|
1.23
+15%
|
1.27
+3%
|
1.16
-9%
|
1.25
+8%
|
1.27
+2%
|
1.33
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
